A Prospective, Multi-center Study to Evaluate Efficacy and Safety of BSJ020R in Treatment of AVF for Hemodialysis (RANGER AV Japan Study)

NARecruitingINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

December 13, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

December 31, 2026

Conditions
Arteriovenous Fistula StenosisArteriovenous FistulaVascular Access
Interventions
DEVICE

RANGER™ Paclitaxel Coated Balloon Catheter

A procedure that utilizes a balloon coated with paclitaxel (drug) which can open up a blocked blood vessel using a small, flexible plastic tube, or catheter, with a balloon coated with paclitaxel at the end of it. When the tube is in place, it inflates to open the blood vessel, so that normal blood flow is restored. The tube is then removed.

Trial Locations (8)

Unknown

RECRUITING

Kansai Rosai Hospital, Amagasaki

RECRUITING

Yokohama Dai-ichi Hospital, Yokohama

COMPLETED

Kishiwada Tokushukai Hospital, Kishiwada

RECRUITING

Osaka Keisatsu Hospital, Osaka

RECRUITING

Saitama Medical Center, Kawagoe

RECRUITING

Shizuoka General Hospital, Shizuoka

RECRUITING

Saiseikai Central Hospital, Minato

RECRUITING

Wakayama Medical University Hospital, Wakayama

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT06639451 - A Prospective, Multi-center Study to Evaluate Efficacy and Safety of BSJ020R in Treatment of AVF for Hemodialysis (RANGER AV Japan Study) | Biotech Hunter | Biotech Hunter